Navigation Links
Insmed Appoints Dennis M. Lanfear to Board Of Directors
Date:12/6/2007

Former Veteran Amgen Executive

RICHMOND, Va., Dec. 6 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today announced the appointment of Mr. Dennis "Denny" Lanfear, 52, to its board of directors. Insmed's board of directors now consists of seven members, five of whom are independent.

Mr. Lanfear spent 13-years at Amgen, Inc., where he was a Corporate Officer and Vice President with broad operational, product development and marketing responsibilities. While at Amgen, Mr. Lanfear held senior leadership positions within multiple product development programs, including those for growth factors, somatotrophins and neurotrophins. He directed efforts from pre-clinical to Phase 3, contributed to more than 20 INDs and BLAs, managed corporate partner relationships and developed long term strategies for Epogen(TM), a multi-billion dollar anemia drug.

"Denny's diverse manufacturing and product development expertise, combined with his insight into the regulatory approval process, will be invaluable to Insmed," said Geoffrey Allan, CEO of Insmed. "In addition, Denny's corporate development and marketing experience will be significant resources for us as we continue moving our follow-on biologics initiative forward, and leverage the substantial market opportunities available to us."

Before joining Amgen, Mr. Lanfear held a number of positions at Baxter International, and was also the founder and CEO of Saronyx, Inc., a drug development software services company. Mr. Lanfear is the founder of InteKrin Therapeutics Inc., a clinical-stage, privately held biopharmaceutical company focused on diabetes metabolism and obesity. He currently serves as InteKrin's President and Chief Executive Officer. He earned degrees in Biochemistry and Chemical Engineering from Michigan State University, and received his MBA from the Anderson School at UCLA.

"I believe Insmed is w
'/>"/>

SOURCE Insmed Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... team led by group leader Yung-Eun Sung has ... synthesize sulfur-doped and nitrogen-doped graphenes which can be ... and fuel cells. Yung-Eun Sung is both a ... at Institute for Basic Science* (IBS) and a ... achievement has great significance with regards to the ...
(Date:7/24/2014)... DUBLIN , July 24, 2014 ... the "Global Genomics and Proteomics Analytical Instruments Market ... http://photos.prnewswire.com/prnh/20130307/600769 Genomics is the ... is the study of the structure and functions of ... and bioinformatics tools and technology. Genomics involves the mapping ...
(Date:7/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on Potassium ... basic information, including its definition, classification, application, ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis, the ...
(Date:7/24/2014)... 24, 2014 Draper University, a ... proud to announce that for 6 weeks this ... will converge on the Draper University campus in ... experiential program focused on entrepreneurship, building real-world skills, ... currently running its sixth cohort, continues to refresh ...
Breaking Biology Technology:Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3
... Laureate To Manufacture Tolera,s Monoclonal Antibody Product ... Laureate Pharma, Inc., a,full-service biopharmaceutical development ... has entered into a cGMP contract manufacturing,agreement ... that,develops and offers targeted therapies and safer ...
... will feature Ziplex automated gene-expression system at the ... ... Xceed Molecular, a pioneer in,the development of cost-effective, easy-to-use ... Dr. James L. Wittliff, a professor in the Department of,Biochemistry ...
... ... Gardner, Mass. (PRWEB) October 28, 2008 -- New England Peptide, ... formed scientific advisory board., , ,Vincent Bille, Tomi Sawyer and Ved ... thought leaders in peptide chemistry. The group will assist in formulating ...
Cached Biology Technology:Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc. 2James L. Wittliff, Ph.D., FACB, to Present 'Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System' at the Association for Molecular Pathology Conference, October 30 2James L. Wittliff, Ph.D., FACB, to Present 'Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System' at the Association for Molecular Pathology Conference, October 30 3New England Peptide Forms Scientific Advisory Board 2New England Peptide Forms Scientific Advisory Board 3New England Peptide Forms Scientific Advisory Board 4
(Date:7/25/2014)... tractography (DTT), which is derived from diffusion tensor ... motor tracts, such as the corticospinal tract, the ... The corticospinal tract is known to be a ... human brain. Several studies have reported on injury ... addition, some studies have demonstrated recovery of a ...
(Date:7/25/2014)... a molecular testing panel developed at UPMC greatly ... surgery for patients with thyroid nodules and cancer, ... Institute (UPCI), partner with UPMC CancerCenter., The test, ... other diagnostic testing agencies, improved the chances of ... percent, according to the study published this month ...
(Date:7/24/2014)... Scientists at The New York Stem Cell Foundation ... creating a viable cell replacement therapy for multiple ... For the first time, NYSCF scientists generated induced ... of patients with primary progressive multiple sclerosis and ... these stem cells into becoming oligodendrocytes, the myelin-forming ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2
... discovered that a poorly understood class of RNA produced in ... the outcome of the infection. Their findings are reported ... Society for Microbiology. RNA (ribonucleic acid) contains information transcribed ... known of these RNAs translate sections of DNA code into ...
... St. Louis, MO, October 26, 2010 Periodontitis, a ... teeth, leads to accumulation of bacteria and potential bone ... bacterial infection, more recent strategies target the inflammatory response. ... Journal of the American Dietetic Association , researchers ...
... Food and Agriculture (NIFA) awarded a $1.5 million grant ... for increasing environmental, social, and economic sustainability in ornamental ... the U of I Department of Crop Sciences said ... crop production systems is waste generation due to the ...
Cached Biology News:New class of biomolecules triggered in response to respiratory virus infection 2New class of biomolecules triggered in response to respiratory virus infection 3New class of biomolecules triggered in response to respiratory virus infection 4Consuming polyunsaturated fatty acids may lower the incidence of gum disease 2U of I receives $1.5 million to further sustainability in ornamental crop production 2U of I receives $1.5 million to further sustainability in ornamental crop production 3
... This product has been developed to significantly ... labeled proteins. Stability is increased at ... 2-8 centigrade. This product is subjected ... mercury or azide. This formulation insures ...
... and conveniently controls the temperature at your lab ... levels up to 99 C*, with the "plus" ... as 5 C. The thermoblocks for 0.2 ml**, ... microplates enable a high degree of flexibility for ...
...
... powerful tool for sample purification in microbiological ... or protein purification as well as cell ... on the Genesis Series of instruments using ... with the RoMa arm and Tecans powerful ...
Biology Products: